Syngene Inks Pact with GSK for Drug Discovery Services

Bengaluru based contract research services firm, Syngene International, has entered into an R&D agreement with healthcare major GSK. The multi-year agreement will focus on accelerating the discovery of new drug candidates using Syngene’s discovery services platform, Sygene said in a statement.

As per this agreement, Syngene will set up a discovery research laboratory to support projects across several therapeutic areas. Also, a team of Syngene scientists will work closely with GSK’s global R&D teams on discovery research projects to identify new drug candidates with the potential to address some of the world’s most pressing healthcare needs. Mr. Jonathan Hunt, Chief Executive Officer, Syngene International, said, “The collaboration in many ways underlines Syngene’s position as an innovative, capable and cost-effective provider of discovery research services to the global pharma industry.”